US

Northwestern Mutual commits $150 mln to form new fund

Northwestern Mutual commits $150 million to form Northwestern Mutual Future Ventures Fund II. The fund will invest in financial tech startups.

Northwestern Mutual commits $150 mln to form new fund

Northwestern Mutual commits $150 million to form Northwestern Mutual Future Ventures Fund II. The fund will invest in financial tech startups.

Whole Biome nets $35 mln Series B

Whole Biome, an evidence-based microbiome company, has secured $35 million in Series B financing. Sequoia Capital led the round with participation from other investors that included True Ventures, Khosla Ventures, Mayo Foundation and AME Cloud Ventures. In addition to the funding, Sequoia Partner Roelof Botha has joined Whole Biome's board of directors.

Whole Biome nets $35 mln Series B

Whole Biome, an evidence-based microbiome company, has secured $35 million in Series B financing. Sequoia Capital led the round with participation from other investors that included True Ventures, Khosla Ventures, Mayo Foundation and AME Cloud Ventures. In addition to the funding, Sequoia Partner Roelof Botha has joined Whole Biome's board of directors.

Dynamk Capital adds venture partner

Dynamk Capital, a venture firm focused on early-stage life sciences companies, has named Dr. Gustavo Mahler as a venture partner. Mahler is the former CEO of AGC Biologics.

Dynamk Capital adds venture partner

Dynamk Capital, a venture firm focused on early-stage life sciences companies, has named Dr. Gustavo Mahler as a venture partner. Mahler is the former CEO of AGC Biologics.

Thrive Earlier Detection Corp snags $110 mln Series A

Cambridge, Massachusetts and Baltimore-based Thrive Earlier Detection Corp, a newly launched company focused on incorporating earlier cancer detection into routine medical care, has raised $110 million in Series A financing. Third Rock Ventures led the round.

Thrive Earlier Detection Corp snags $110 mln Series A

Cambridge, Massachusetts and Baltimore-based Thrive Earlier Detection Corp, a newly launched company focused on incorporating earlier cancer detection into routine medical care, has raised $110 million in Series A financing. Third Rock Ventures led the round.

TFF Pharmaceuticals rakes in $8.17 mln

TFF Pharmaceuticals Inc, an early-stage biopharmaceutical company focused on treating chronic respiratory diseases and lung conditions, has secured $8.17 million in funding. The investors were not named.

OurCrowd taps Ellison as board chairman

Israel-based OurCrowd, an equity crowdfunding platform, has named Alec Ellison as chairman of the board. Ellison is a former vice chairman of Jefferies and founder of Outvest Capital.